GCLC and lymphoid neoplasm: To investigate whether increased glutathione biosynthesis accounts for TIC-like survival within a 3D gel, we treated lymphoid tumor cells with DL-Buthionine-sulphoximine (BSO), a pharmacological inhibitor of GCL-mediated glutathione biosynthesis.